# Treatment of Japanese Encephalitis

> **NCT00216268** · PHASE2 · UNKNOWN · sponsor: **Indian Council of Medical Research** · enrollment: 200 (—)

## Conditions studied

- Japanese Encephalitis

## Interventions

- **DRUG:** Ribavirin

## Key facts

- **NCT ID:** NCT00216268
- **Lead sponsor:** Indian Council of Medical Research
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2005-07
- **Primary completion:** —
- **Final completion:** 2008-05
- **Target enrollment:** 200 (—)
- **Last updated:** 2006-02-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00216268

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00216268, "Treatment of Japanese Encephalitis". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00216268. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*